UPDATE: Personalis, Inc. (PSNL) Tops Q2 EPS by 5c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. FND
9. DASH
10. GILD

Go back to UPDATE: Personalis, Inc. (PSNL) Tops Q2 EPS by 5c, Revenues Beat

Personalis Reports Second Quarter 2020 Financial Results

August 6, 2020 4:01 PM EDT

MENLO PARK, Calif.--(BUSINESS WIRE)-- Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today reported financial results for the second quarter ended June 30, 2020.

Second Quarter Highlights

Reported record revenues of $19.5 million in the second quarter of 2020 versus $15.8 million in the second quarter of 2019, an increase of 23% A total of 32 customers have placed orders for NeXT as of June 30, 2020, with 6 of those customers placing their first orders in the second quarter of 2020 Announced a collaboration with Sarepta Therapeutics, Inc. (Nasdaq:... More